James M. Burke

7.7k total citations · 1 hit paper
82 papers, 3.8k citations indexed

About

James M. Burke is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, James M. Burke has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 23 papers in Genetics and 23 papers in Immunology. Recurrent topics in James M. Burke's work include RNA Research and Splicing (24 papers), Virus-based gene therapy research (23 papers) and Cancer Research and Treatments (20 papers). James M. Burke is often cited by papers focused on RNA Research and Splicing (24 papers), Virus-based gene therapy research (23 papers) and Cancer Research and Treatments (20 papers). James M. Burke collaborates with scholars based in United States, South Korea and Canada. James M. Burke's co-authors include Roy Parker, Christopher S. Sullivan, Rodney P. Kincaid, David H. Kirn, Caroline J. Breitbach, Evan Lester, Soraya I. Shehata, James A. Hay, Daniel B. Larremore and Bryan Wilder and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

James M. Burke

79 papers receiving 3.7k citations

Hit Papers

Test sensitivity is secondary to frequency and turnaround... 2021 2026 2022 2024 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
    2021 565 citations Evan Lester, Soraya I. Shehata et al. Science Advances profile →

Peers

James M. Burke
Lung‐Ji Chang United States
Andrew J. Bett United States
Rosa María Díaz United States
Mark J. Federspiel United States
Dorotheé von Laer Germany
Michael J. Imperiale United States
David A. Ornelles United States
Igor P. Dmitriev United States
Steve Pascolo Switzerland
Yosef Refaeli United States
Lung‐Ji Chang United States
James M. Burke
Citations per year, relative to James M. Burke James M. Burke (= 1×) peers Lung‐Ji Chang

Countries citing papers authored by James M. Burke

Since Specialization
Citations

This map shows the geographic impact of James M. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Burke more than expected).

Fields of papers citing papers by James M. Burke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Burke. The network helps show where James M. Burke may publish in the future.

Co-authorship network of co-authors of James M. Burke

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Burke. A scholar is included among the top collaborators of James M. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Burke. James M. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caine, Elizabeth A., et al.. (2025). A Live-Cell NanoBRET Assay to Monitor RNA–Protein Interactions and Their Inhibition by Small Molecules. ACS Central Science. 11(11). 2154–2171.
2.
Shehata, Soraya I., et al.. (2024). Mechanisms and consequences of mRNA destabilization during viral infections. Virology Journal. 21(1). 38–38. 5 indexed citations
3.
Ye, Chengjin, Abhishek Asthana, Li Tan, et al.. (2024). SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling. Proceedings of the National Academy of Sciences. 121(15). e2320194121–e2320194121. 18 indexed citations
4.
Li, Roger, Paras Shah, Tyler F. Stewart, et al.. (2024). Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature Medicine. 30(8). 2216–2223. 25 indexed citations
5.
Li, Roger, Philippe E. Spiess, Wade J. Sexton, et al.. (2023). Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 41(16_suppl). e16613–e16613. 1 indexed citations
6.
Burke, James M., et al.. (2022). Nucleic acid–protein condensates in innate immune signaling. The EMBO Journal. 42(7). e111870–e111870. 18 indexed citations
7.
Burke, James M., Nina Ripin, Max Ferretti, et al.. (2022). RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus. PLoS Pathogens. 18(11). e1010930–e1010930. 23 indexed citations
8.
Burke, James M., Alison R. Gilchrist, Sara L. Sawyer, & Roy Parker. (2021). RNase L limits host and viral protein synthesis via inhibition of mRNA export. Science Advances. 7(23). 26 indexed citations
9.
Burke, James M., et al.. (2021). ADAR1 limits stress granule formation through both translation-dependent and translation-independent mechanisms. Journal of Cell Science. 134(17). 13 indexed citations
10.
Burke, James M., et al.. (2021). SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block. RNA. 27(11). 1318–1329. 64 indexed citations
11.
Brocard, Michèle, Valentina Iadevaia, Belinda S. Hall, et al.. (2020). Norovirus infection results in eIF2α independent host translation shut-off and remodels the G3BP1 interactome evading stress granule formation. PLoS Pathogens. 16(1). e1008250–e1008250. 36 indexed citations
12.
Burke, James M., Evan Lester, Devin Tauber, & Roy Parker. (2020). RNase L promotes the formation of unique ribonucleoprotein granules distinct from stress granules. Journal of Biological Chemistry. 295(6). 1426–1438. 57 indexed citations
13.
Burke, James M., et al.. (2018). The Murine Polyomavirus MicroRNA Locus Is Required To Promote Viruria during the Acute Phase of Infection. Journal of Virology. 92(16). 13 indexed citations
14.
Breitbach, Caroline J., John C. Bell, Tae-Ho Hwang, David H. Kirn, & James M. Burke. (2015). The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594). PubMed. 4. 25–25. 46 indexed citations
15.
Park, Se Hoon, Caroline J. Breitbach, Jeeyun Lee, et al.. (2015). Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer. Molecular Therapy. 23(9). 1532–1540. 140 indexed citations
16.
Breitbach, Caroline J., Rozanne Arulanandam, Naomi De Silva, et al.. (2013). Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans. Cancer Research. 73(4). 1265–1275. 208 indexed citations
17.
Seo, Gil Ju, Rodney P. Kincaid, James M. Burke, et al.. (2013). Reciprocal Inhibition between Intracellular Antiviral Signaling and the RNAi Machinery in Mammalian Cells. Cell Host & Microbe. 14(4). 435–445. 151 indexed citations
18.
Hwang, Tae-Ho, Anne Moon, James M. Burke, et al.. (2011). A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma. Molecular Therapy. 19(10). 1913–1922. 122 indexed citations
19.
Nemunaitis, John, Alex W. Tong, Michael Nemunaitis, et al.. (2009). A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors. Molecular Therapy. 18(2). 429–434. 205 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lung‐Ji Chang Breakdown of academic impact, for papers by Andrew J. Bett Breakdown of academic impact, for papers by Rosa María Díaz Breakdown of academic impact, for papers by Mark J. Federspiel Breakdown of academic impact, for papers by Dorotheé von Laer Breakdown of academic impact, for papers by Michael J. Imperiale Breakdown of academic impact, for papers by David A. Ornelles Breakdown of academic impact, for papers by Igor P. Dmitriev Breakdown of academic impact, for papers by Steve Pascolo Breakdown of academic impact, for papers by Yosef Refaeli
Rankless by CCL
2026